A detailed history of Fmr LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fmr LLC holds 169,661 shares of BMRN stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169,661
Previous 486,483 65.12%
Holding current value
$11.3 Million
Previous $42.5 Million 67.13%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$74.43 - $92.22 $23.6 Million - $29.2 Million
-316,822 Reduced 65.12%
169,661 $14 Million
Q1 2024

May 13, 2024

SELL
$83.81 - $99.0 $48.9 Million - $57.8 Million
-583,498 Reduced 54.53%
486,483 $42.5 Million
Q4 2023

Feb 13, 2024

BUY
$76.22 - $98.51 $27.1 Million - $35.1 Million
356,184 Added 49.9%
1,069,981 $103 Million
Q3 2023

Nov 13, 2023

BUY
$85.07 - $94.48 $14.1 Million - $15.7 Million
166,219 Added 30.36%
713,797 $63.2 Million
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $352,874 - $408,321
-4,071 Reduced 0.74%
547,578 $47.5 Million
Q1 2023

May 11, 2023

BUY
$87.74 - $117.27 $7.58 Million - $10.1 Million
86,382 Added 18.57%
551,649 $53.6 Million
Q4 2022

Feb 13, 2023

SELL
$80.93 - $108.63 $17.7 Million - $23.8 Million
-218,745 Reduced 31.98%
465,267 $48.2 Million
Q3 2022

Nov 10, 2022

BUY
$82.16 - $96.94 $13.9 Million - $16.5 Million
169,732 Added 33.0%
684,012 $58 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $17.8 Million - $21.6 Million
248,829 Added 93.74%
514,280 $42.6 Million
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $6.26 Million - $7.81 Million
84,230 Added 46.48%
265,451 $20.5 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $7.93 Million - $10.1 Million
110,600 Added 156.61%
181,221 $16 Million
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $272,387 - $311,367
3,643 Added 5.44%
70,621 $5.46 Million
Q2 2021

Aug 13, 2021

BUY
$75.51 - $84.79 $5.06 Million - $5.68 Million
66,978 New
66,978 $5.59 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.